Granulocyte FACS phagocytosis assay: Difference between revisions
Jump to navigation
Jump to search
Created page with "{| class="wikitable" |+ !Material ! ! ! |- | |Freshly isolated granulocytes | | |- | |Phagocytosis buffer (PBS, 0.9 mM CaCl<sub>2</sub>; 0.5 mM MgCl<sub>2</sub>; 5 mM glucose; 1% heat inactivated FCS) | | |- | |5-(6)-carboxyfluorescein succinimidyl ester (FAM SE; CFSE, Fluorescein, FITC) | | |- | |Trypan Blue solution | | |} === Preparations === Two days before experiment: streak out gonococci on selective agar plates and select colony morphology one day before infectio..." |
No edit summary |
||
| Line 2: | Line 2: | ||
|+ | |+ | ||
!Material | !Material | ||
! | ! | ||
|- | |- | ||
| | | | ||
|Freshly isolated granulocytes | |Freshly isolated granulocytes | ||
|- | |- | ||
| | | | ||
|Phagocytosis buffer (PBS, 0.9 mM CaCl<sub>2</sub>; 0.5 mM MgCl<sub>2</sub>; 5 mM glucose; 1% heat inactivated FCS) | |Phagocytosis buffer (PBS, 0.9 mM CaCl<sub>2</sub>; 0.5 mM MgCl<sub>2</sub>; 5 mM glucose; 1% heat inactivated FCS) | ||
|- | |- | ||
| | | | ||
|5-(6)-carboxyfluorescein succinimidyl ester (FAM SE; CFSE, Fluorescein, FITC) | |5-(6)-carboxyfluorescein succinimidyl ester (FAM SE; CFSE, Fluorescein, FITC) | ||
|- | |- | ||
| | | | ||
|Trypan Blue solution | |Trypan Blue solution | ||
|} | |} | ||
Latest revision as of 18:11, 15 February 2025
| Material | |
|---|---|
| Freshly isolated granulocytes | |
| Phagocytosis buffer (PBS, 0.9 mM CaCl2; 0.5 mM MgCl2; 5 mM glucose; 1% heat inactivated FCS) | |
| 5-(6)-carboxyfluorescein succinimidyl ester (FAM SE; CFSE, Fluorescein, FITC) | |
| Trypan Blue solution |
Preparations
Two days before experiment: streak out gonococci on selective agar plates and select colony morphology one day before infection, when you streak on regular GC plates.
Procedure
- Isolate granulocytes according to protocol. During granulocyte isolation, label bacteria with fluorescein so that isolated granulocytes can be infected without delay.
- Bacteria are taken from plates (cultures not older than 18 h), suspended in PBS and bacterial suspension is set to 4 x 108 bacteria/ml. Bacteria are labeled with 5- (6)-carboxyfluorescein succinimidyl ester (FAM SE; CFSE) (2 mg/ml stock in DMSO) using a 1:2000 dilution (0.5 µl in 1ml of bacterial suspension) for 20 min in the dark at RT on a shaker. Centrifuge at 4000 rpm for 4 min and wash the pellet 3 times with phosphate- buffered saline (PBS).
- Isolated granulocytes are resuspended in phagocytosis buffer and adjusted to a concentration of 1X106/ml in eppi-tubes.
- If required, add pharmacological inhibitors at the desired concentration to the granulocytes and rotate (8 rpm) on a wheel rotating platform for 10 min at 37°C prior to infection.
- Take 50 µl of labelled bacteria (2 x 107 bacteria) to infect 1 x 106 (1 ml) of granulocytes (resulting in a multiplicity of infection/MOI of 20). Leave one granulocyte sample uninfected. Incubate for 15 min at 37°C with 8 rpm.
- Phagocytosis is stopped by addition of ice-cold PBS. Samples are washed and taken up in ice-cold FACS-buffer (PBS, 2 % h.i. FCS, 0.05 % NaN3) and analysed by FACS.
- Set up FACS parameters (FSC, SSC) with uninfected control, gate on granulocyte population. Set channel voltage on the flow cytometer while measuring CFSE fluorescence (488 nm excitation; 525 nm emission) using negative/ positive control samples. Measure 10.000 cells for each sample. Immediately after running of each tube, add 500 µl neutrophil-supension to 500 µl of trypan blue solution (0.4 mg/ml) for a final trypan blue concentration of 0.2 mg/ml. Mix and measure the fluorescence signals again.
- To determine the number of phagocytosed bacteria use the percentage of CFSE- positive cells (percentage of cells with intracellular bacteria) and multiply this number by the mean fluorescence intensity of the CFSE-positive cell population. This number is refered to as the uptake index.